12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Company News  |  Other News

Warner Chilcott, Impax, Mylan infectious news

Warner Chilcott said the U.S. District Court for the District of New Jersey ruled in favor of Mylan and Impax in a patent infringement suit brought by Warner Chilcott related to a generic version of 150 mg Doryx doxycycline delayed-release tablets. Although the court upheld the validity of U.S. Patent No. 6,958,161 covering Doryx, the...

Read the full 263 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >